Drug Search Results
More Filters [+]

Exbivirumab

Alternative Names: exbivirumab
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: CD80 Binder,CD86 Binder

Novel Mechanism: Yes

Modality: Antibody

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: XTL
Company Location: NEW YORK NY 10016
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Exbivirumab

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis B

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2004-000501-21

P2

Completed

Hepatitis B

2005-08-30

Recent News Events

Date

Type

Title